TheraRadar
← Back
Data updated: Mar 29, 2026

USL PHARMA

NeurologyCardiovascularGastroenterology
Generics

USL PHARMA is a generic drug manufacturer focused on Neurology, Cardiovascular, Gastroenterology.

1976
Since
56
Drugs
-
Trials
455
Approved (2yr)

Key Drugs

No active drugs

Top Drug Revenues Pro

Loading...

Revenue Over Time Pro

Loading...

Recent Activity

SULFAMETHOXAZOLE AND TRIMETHOPRIM 2026-02-10
Labeling
TRAZODONE HYDROCHLORIDE 2026-02-09
Labeling
TRAZODONE HYDROCHLORIDE 2026-02-09
Labeling
ESTRADIOL 2026-02-02
ESTRADIOL 2026-01-22
Labeling
AMITRIPTYLINE HYDROCHLORIDE 2026-01-09
Labeling
HYDROCODONE BITARTRATE AND ACETAMINOPHEN 2026-01-08
Labeling
CARBAMAZEPINE 2026-01-05
Labeling
SEC Filings Pro
Loading...

Therapeutic Areas

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

Neurology 40%
4 drugs
Cardiovascular 30%
3 drugs
Gastroenterology 10%
1 drugs
Immunology 10%
1 drugs
Oncology 10%
1 drugs

Pipeline Forecast

Loading...

Upcoming Trial Milestones Pro

Loading...

Patent Cliff Pro

Loading...

Competitors by Therapeutic Area

Bristol-Myers Squibb big-pharma
Oncology, Immunology, Gastroenterology, Neurology
Pfizer big-pharma
Oncology, Immunology, Gastroenterology
Takeda big-pharma
Immunology, Oncology, Gastroenterology, Neurology
Novartis big-pharma
Oncology, Cardiovascular, Immunology
Merck big-pharma
Oncology, Cardiovascular, Immunology